期刊文献+

用踝肱血压比评价2型糖尿病患者周围血管疾病及相关危险因素 被引量:3

Peripheral vascular disease in type 2 diabetic patients evaluated by ankle-brachial index and relative risk factors
下载PDF
导出
摘要 目的用踝肱血压比(AB I)评价2型糖尿病患者周围血管疾病(PVD)发病情况及相关危险因素。方法选择113例门诊50岁以上的2型糖尿病患者,收集病史,检测代谢指标,检测双下肢AB I,以AB I<0.9定义为存在PVD。结果在2型糖尿病患者中PVD检出率16.8%。血糖控制差(GHbA1c≥7.5%)的患者中PVD的检出率明显高于血糖控制好至一般的患者(P=0.01)。合并PVD的2型糖尿病患者的年龄、甘油三酯水平、糖尿病病程、冠心病共患病率和吸烟率高于不合并PVD的患者(P<0.05),合并PVD组的患者血清超敏C反应蛋白水平明显高于不合并PVD组(P<0.01)。结论本研究发现在2型糖尿病患者中PVD的患病率为16.8%。与PVD相关的危险因素包括高龄、高甘油三酯、糖尿病病程长、同时患有冠心病和吸烟,以及较高的血清超敏C反应蛋白水平。因此对于存在以上危险因素的2型糖尿病患者应该加强对PVD的筛查。 Objective To evaluate the prevalence of peripheral vascular disease (PVD) in type 2 diabetic patients by ankle-brachial index (ABI) and relative risk factors for PVD. Methods We recruited 113 type 2 diabetic patients from out-patient clinic, collected medical history and fasting blood sample for measurement of metabolic indexes. We screened the patients by ABI, and PVD was defined by ABI 〈0.9. Results The PVD prevalence was 16.8% in 113 type 2 diabetic patients. Patients of poor blood glucose control (GHbA1c≥7.5%) had higher prevalence of PVD than patients who had good to normal glucose control (P = 0.01 ). Diabetic patients witb PVD had older age, higher triglyceride level, longer diabetic duration, higher prevalence of CHD and smoking ( P 〈 0.05 ), and much higher serum hsCRP level (P 〈0.01 ) than diabetic patients without PVD. Conclusion We found the prevalence of PVD was 16.8% in type 2 diabetic patients. Risk factors for PVD in diabetic patients including older age, higher serum triglyceride level, longer duration of diabetes, combined with CHD and smoking, and much higher serum hsCRP level. So we should screen diabetic patients with those risk factors.
出处 《中国医刊》 CAS 2007年第2期28-30,共3页 Chinese Journal of Medicine
关键词 踝肱血压比 周围血管疾病 超敏C反应蛋白 2型糖尿病 ABI PVD hsCRP type 2 diabetes
  • 相关文献

参考文献8

  • 1Walters DP,Gatling W,Mullee MA et al.The prevalence,detection,and epidemiologicai correlales of peripheral vascular disease:a comparison of diabetic and non-diabetic subjects in an English cornmunity[J].Diabetic Medicine,1992,9:710-715.
  • 2Siitonen OI,Niskanen LK,Laakso M et al.Lower-extremity amputation in diabetic and non-diabetic patients:a population-based study in Eastern Finland[J].Diabetes Care,1993,16:16-20.
  • 3王领军,胡大一,吴华,闫明珠,逯春鹏,魏毅东,余金明,布艾加尔,仝其广,王锦纹.踝臂指数评价血液透析患者下肢外周动脉病多中心临床研究[J].中国医刊,2005,40(6):32-34. 被引量:13
  • 4Chin-Hsiao Tseng.Prevalence and risk factors of peripheral arterial obstructive disease in Taiwan Residents type 2 diabetic patients[J].Angiology,2003,54(3):331-338.
  • 5H-I Yu,W.H-H.Sheu,Y-M.Song et al.C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus[J].Diabetic Medicine,2004,21:336-341.
  • 6Ridker PM,Cushman M,Stampfer M,et al.Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease[J].Circulation,1998,97:425-428.
  • 7Ridker PM,Hennekens CH,Buring JE,et al.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J].N Engl J Med,2000,342:836-843.
  • 8Chin-Hsiao Tseng.Pulse pressure as a risk factor for peripheral vascular disease in type 2 diabetic patients[J].Clinical and Experimental Hypertension,2003,25(8):475-485.

二级参考文献13

  • 1Hiatt WR. Medical treatment of peripheral arterial disease and claudication [J]. N Engl Med 2001,344∶1608~1621.
  • 2Dieter RS, Chu WW, Pacanowski JP, et al . The significance of lower extremity peripheral disease [J]. Clin Cardiol,2002; 25∶3~10.
  • 3Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care [J]. JAMA, 2001,286∶1317~1324.
  • 4O'Hare A, Glidden DV, Fox CS et al. High prevalence of peripheral arterial disease in persons with renal insufficiency [J]. Circulation, 2004,109∶320~323.
  • 5Leskinen Y, Salenius JP, Lehtimaki T, et al. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: Requirements for Diagnostics [J]. Am J Kidney Dis, 2002,40(No.3)∶472~479.
  • 6Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J]. Kidney Int, 2000,58∶353~262.
  • 7O'Hare A, Hsu CY, Bacchetti P, et al. Peripheral vascular disease risk factors among patients undergoing hemodialysis [J]. J Am Soc Nephrol, 2002,13∶497-503.
  • 8TASC Working Group. Management of peripheral arterial disease [J]. J Vasc Surg, 2003,31(1 suppl )∶S1~S296.
  • 9Leng GC, Papacosta O, Whincup P, et al. Femoral atherosclerosis in an old British population: prevalence and risk factors [J]. Atherosclerosis, 2002,152∶167~174.
  • 10Jousse L, Levy D, Murabito JM, et al. Alcohol consumption and risk of intermittent claudication in the Framingham Heart Study[J]. Circulation ,2002,102∶3092~3097.

共引文献12

同被引文献24

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部